[Hepatotoxicity associated with tumor immune checkpoint inhibitors].
Zhonghua Gan Zang Bing Za Zhi
; 28(2): 175-178, 2020 Feb 20.
Article
in Zh
| MEDLINE
| ID: mdl-32164073
ABSTRACT
Although tumor immune checkpoint inhibitors therapy brings survival benefits to cancer patients, it also faces many challenges, such as the occurrence of immune-mediated hepatotoxicity. Therefore, an in-depth understanding of the conditions, possible mechanisms, and risk factors that cause liver injury during the treatment of tumor immune checkpoint inhibitors will facilitate better clinical management.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug-Related Side Effects and Adverse Reactions
/
Chemical and Drug Induced Liver Injury
/
Antineoplastic Agents, Immunological
/
Immunotherapy
/
Liver
/
Neoplasms
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
Zh
Journal:
Zhonghua Gan Zang Bing Za Zhi
Journal subject:
GASTROENTEROLOGIA
Year:
2020
Document type:
Article
Affiliation country:
China